Nuvastatic

N/A

Report date: 2025/12/15 20:00:38

Base Information

Drug NameNuvastatic
Drug Alias NameN/A
ClassificationBiologicsNatural product/Extract > Plants extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Diabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNatureceuticals Sdn Bhd
China Registration ClassN/A

Develop Information

Active CompaniesNatureceuticals Sdn Bhd
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A